Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W2032487234
